发明名称 FORMULATIONS OF RECOMBINANT HUMAN BILE SALT-STIMULATED LIPASE
摘要 The present invention relates to improved formulations of recombinant human bile salt stimulated lipase (rhBSSL), including those suitable for forming a lyophilized formulation of rhBSSL, lyophilized formulations of rhBSSL per-se, unit dose forms of rhBSSL and reconstituted formulations of rhBSSL. The formulations of the present invention comprises rhBSSL, a crystalline bulking agent and an amorphous stabilizer that is a different chemical entity to said crystalline bulking agent. The formulations of the present invention have one or more desired properties, including those that relate to stability, decreased aggregation and/or formation of insoluble aggregates in solution. The lyophilized formulations of the present invention have pharmaceutical utility, particularly for the administration of rhBSSL to human infants.
申请公布号 US2015191714(A1) 申请公布日期 2015.07.09
申请号 US201214346296 申请日期 2012.09.25
申请人 Swedish Orphan Biovitrum AB(Publ) 发明人 Ek Vilhelm
分类号 C12N9/96;C12N9/20 主分类号 C12N9/96
代理机构 代理人
主权项 1. A formulation suitable for lyophilization comprising: (i) recombinant human bile salt-stimulated lipase (rhBSSL); (ii) a crystalline bulking agent; and (iii) an amorphous stabilizer that is a different chemical entity to said crystalline bulking agent and is present at a relative amount of between about 0.1 mg and about 0.5 mg per mg of said rhBSSL.
地址 Stockholm SE